Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05784714
Other study ID # R34AA02896m
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 14, 2023
Est. completion date May 31, 2024

Study information

Verified date April 2024
Source Tulane University
Contact Gretchen Clum, PhD
Phone 504-988-4536
Email gclum@tulane.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of the proposed research is to conduct formative work to develop, pilot and refine a smartphone delivered intervention for violence affected people living with HIV utilizing a novel spatial-temporal methodology, geographical ecological momentary assessment (GEMA), to first identify the activity spaces and daily psychosocial experiences (mental health symptoms, substance use, self-efficacy, coping) impacting adherence and viral suppression, and apply them to intervention. Guided by an ecological perspective, the investigators will adapt Living in the Face of Trauma to a mobile platform with GEMA informed intervention targets. The resulting app shall be referred to as NOLA GEM. Our long-term goal is delivering accessible interventions informed by daily experiences that affect health for PLWH. The investigators will test feasibility, acceptability and preliminary efficacy of the GEMA-informed NOLA GEM app against GEMA alone on adherence and care, and secondary outcomes of mental health and substance use.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date May 31, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Having a reported HIV infection and being on ART. Exclusion Criteria: -

Study Design


Intervention

Behavioral:
NOLA GEM
This is a mobile application that has 6 psychoeducational sessions and related skills, local resources, and a way for participants to track their progress. Further information is in the arm descriptions.

Locations

Country Name City State
United States Access Health Louisiana New Orleans Louisiana
United States CrescentCare New Orleans Louisiana
United States Institute of Women & Ethnic Studies New Orleans Louisiana
United States Women With A Vision New Orleans Louisiana

Sponsors (1)

Lead Sponsor Collaborator
Tulane University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence Self report taking all HIV-related medication and treatment in past 30 days 30 day post-assessment
Primary Viral Load Self report last blood draw was under 50 copies of HIV/mL in past 90 days 90 days post assessment
Primary Care Engagement Self report % of missed appointments in past 90 days 90 days post assessment
Primary Care Engagement HIV Treatment Adherence Self-Efficacy Scale; 0-120; higher score means more self-efficacy for care engagement 30 days post assessment
Primary Acceptability of intervention User Experience Questionnaire-Short Form 30 day post-assessment
Primary Acceptability of intervention Net Promotor Score; 0-10; higher score means more likely to recommend to a friend 30 day post-assessment
Primary Feasibility of intervention App usage paradata 30 day post-assessment
Primary Feasibility of intervention Participation rates 30 day post-assessment
Secondary PTSD PTSD Checklist for DSM-5; higher scores indicate higher levels of PTSD symptomology 30 day post-assessment
Secondary Depression, anxiety Hospital Anxiety Depression Scale; 0-21; higher scores indicate higher levels of anxiety and/or depression 30 day post-assessment
Secondary Stress Study generated daily stressors severity checklist 30 day post-assessment
Secondary Stress Perceived Stress Scale 4; 0-16; higher score is correlated to more stress 30 day post-assessment
Secondary Coping Brief-COPE; higher scores indicate higher levels of emotion focused, problem focused, and avoidant coping styles 30 day post-assessment
Secondary Coping adapted Coping Self-Efficacy Scale; higher score means more coping self-efficacy 30 day post-assessment
Secondary Substance use Adapted Addiction Severity Index 30 day post-assessment
Secondary Substance use Alcohol Use Disorders Identification Test-C; 0-12; higher score indicates more problematic drinking 30 day post-assessment
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2